Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Jun 1;6(6):e2321281.
doi: 10.1001/jamanetworkopen.2023.21281.

Incidence of Diabetes in Children and Adolescents During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

Incidence of Diabetes in Children and Adolescents During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis

Daniel D'Souza et al. JAMA Netw Open. .

Abstract

Importance: There are reports of increasing incidence of pediatric diabetes since the onset of the COVID-19 pandemic. Given the limitations of individual studies that examine this association, it is important to synthesize estimates of changes in incidence rates.

Objective: To compare the incidence rates of pediatric diabetes during and before the COVID-19 pandemic.

Data sources: In this systematic review and meta-analysis, electronic databases, including Medline, Embase, the Cochrane database, Scopus, and Web of Science, and the gray literature were searched between January 1, 2020, and March 28, 2023, using subject headings and text word terms related to COVID-19, diabetes, and diabetic ketoacidosis (DKA).

Study selection: Studies were independently assessed by 2 reviewers and included if they reported differences in incident diabetes cases during vs before the pandemic in youths younger than 19 years, had a minimum observation period of 12 months during and 12 months before the pandemic, and were published in English.

Data extraction and synthesis: From records that underwent full-text review, 2 reviewers independently abstracted data and assessed the risk of bias. The Meta-analysis of Observational Studies in Epidemiology (MOOSE) reporting guideline was followed. Eligible studies were included in the meta-analysis and analyzed with a common and random-effects analysis. Studies not included in the meta-analysis were summarized descriptively.

Main outcomes and measures: The primary outcome was change in the incidence rate of pediatric diabetes during vs before the COVID-19 pandemic. The secondary outcome was change in the incidence rate of DKA among youths with new-onset diabetes during the pandemic.

Results: Forty-two studies including 102 984 incident diabetes cases were included in the systematic review. The meta-analysis of type 1 diabetes incidence rates included 17 studies of 38 149 youths and showed a higher incidence rate during the first year of the pandemic compared with the prepandemic period (incidence rate ratio [IRR], 1.14; 95% CI, 1.08-1.21). There was an increased incidence of diabetes during months 13 to 24 of the pandemic compared with the prepandemic period (IRR, 1.27; 95% CI, 1.18-1.37). Ten studies (23.8%) reported incident type 2 diabetes cases in both periods. These studies did not report incidence rates, so results were not pooled. Fifteen studies (35.7%) reported DKA incidence and found a higher rate during the pandemic compared with before the pandemic (IRR, 1.26; 95% CI, 1.17-1.36).

Conclusions and relevance: This study found that incidence rates of type 1 diabetes and DKA at diabetes onset in children and adolescents were higher after the start of the COVID-19 pandemic than before the pandemic. Increased resources and support may be needed for the growing number of children and adolescents with diabetes. Future studies are needed to assess whether this trend persists and may help elucidate possible underlying mechanisms to explain temporal changes.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Cohen reported receiving grants from the Canadian Institutes of Health Research outside the submitted work and being a member of the Committee to Evaluate Drugs, which provides advice on public drug policy to Ontario’s Ministry of Health. Dr Shulman reported receiving grants from The Hospital for Sick Children’s Department of Paediatrics during the conduct of the study and receiving grants from the Canadian Institutes of Health Research and speaking fees from Dexcom outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Flow Diagram of Study Selection
Figure 2.
Figure 2.. Forest Plots of Incidence Rate Ratios (IRRs)
Squares indicate IRRs, with horizontal lines indicating 95% CIs and the size of the squares representing weight; diamonds indicate pooled estimates, with outer points of the diamonds indicating 95% CIs. DKA indicates diabetic ketoacidosis; NA, not applicable; T1D, type 1 diabetes.

Comment in

References

    1. Gregory GA, Robinson TIG, Linklater SE, et al. ; International Diabetes Federation Diabetes Atlas Type 1 Diabetes in Adults Special Interest Group . Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol. 2022;10(10):741-760. doi:10.1016/S2213-8587(22)00218-2 - DOI - PubMed
    1. Lawrence JM, Divers J, Isom S, et al. ; SEARCH for Diabetes in Youth Study Group . Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017. JAMA. 2021;326(8):717-727. doi:10.1001/jama.2021.11165 - DOI - PMC - PubMed
    1. Schmitt JA, Ashraf AP, Becker DJ, Sen B. Changes in type 2 diabetes trends in children and adolescents during the COVID-19 pandemic. J Clin Endocrinol Metab. 2022;107(7):e2777-e2782. doi:10.1210/clinem/dgac209 - DOI - PMC - PubMed
    1. Rahmati M, Keshvari M, Mirnasuri S, et al. . The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: a systematic review and meta-analysis. J Med Virol. 2022;94(11):5112-5127. doi:10.1002/jmv.27996 - DOI - PMC - PubMed
    1. Barrett CE, Koyama AK, Alvarez P, et al. . Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years—United States, March 1, 2020–June 28, 2021. MMWR Morb Mortal Wkly Rep. 2022;71(2):59-65. doi:10.15585/mmwr.mm7102e2 - DOI - PMC - PubMed

Publication types